Send me a link:

*Text messaging rates may apply.

 Dow Down 1.34% Nasdaq Down 1.61%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
49.60 Down 1.57(3.07%) 1:52PM EDT - Nasdaq Real Time Price
Prev Close:51.17
Open:50.42
Bid:49.75 x 100
Ask:49.86 x 100
1y Target Est:83.80
Beta:0.95
Next Earnings Date: 4-Aug-14LGND Earnings announcement
Day's Range:49.30 - 51.67
52wk Range:36.82 - 80.42
Volume:166,180
Avg Vol (3m):303,977
Market Cap:1.03B
P/E (ttm):85.08
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDDown 3.07%1.03B
LLYDown 2.17%65.65B
MRKDown 1.24%168.67B
RHHBYDown 0.96%247.81B

Key Statistics

Forward P/E (1 yr):20.55
P/S (ttm):19.90
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.44
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback